Walgreens Boots Alliance, Inc.’s Stock Price Takes a Dip at $17.89, Marking a 2.51% Decrease

Walgreens Boots Alliance, Inc. (WBA)

17.89 USD -0.46 (-2.51%) Volume: 7.94M

Walgreens Boots Alliance, Inc.’s stock price stands at 17.89 USD, witnessing a downwards shift of -2.51% in the current trading session with a trading volume of 7.94M, reflecting a significant year-to-date percentage change of -31.48%, underlining a turbulent performance for WBA stock in the market.

Latest developments on Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance stock experienced significant movements today following reports that the company is seeking potential buyers for its Boots UK chain. Bloomberg News reported that the drugstore giant is looking to sell off its UK-based pharmacies, causing a surge in the stock price. This news comes as no surprise, as Walgreens has previously attempted to sell off Boots in the past. The company’s decision to explore selling its UK chain has sparked investor interest and speculation, leading to a boost in market sentiment and stock performance. Additionally, Walgreens recently announced plans to sell a generic version of the over-the-counter drug Narcan, further impacting its stock price. With ongoing developments, investors are closely monitoring Walgreens Boots Alliance for potential opportunities in the market.

Walgreens Boots Alliance, Inc. on Smartkarma

Analysts on Smartkarma have been closely following Walgreens Boots Alliance, with insights from Baptista Research and Travis Lundy shedding light on the company’s performance and future prospects. Baptista Research‘s report, “Walgreens Boots Alliance Inc.: Redefining Relationships & Creating Value with Payers! – Major Drivers,” highlights the company’s second-quarter operational results meeting expectations despite challenges in the U.S. retail sector. The report evaluates various factors influencing the company’s valuation using a Discounted Cash Flow methodology. On the other hand, Travis Lundy’s analysis, “Walgreens Boots Alliance (WBA US) – How Do Dow Jones Deletes Do Historically?” discusses the company’s removal from the Dow Jones Industrial Average and its implications for future performance compared to its peers.

A look at Walgreens Boots Alliance, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Walgreens Boots Alliance has a strong dividend score of 5, indicating a promising outlook for investors looking for stable income. However, the company’s growth and resilience scores are lower at 2, suggesting potential challenges in these areas. With a value score of 4, Walgreens Boots Alliance may be considered a good value investment. The momentum score of 3 indicates moderate market momentum for the company.

Walgreens Boots Alliance, Inc., is a retail drugstore chain that provides a wide range of prescription and non-prescription drugs, as well as various general merchandise. In addition to its retail offerings, Walgreens also provides health services such as primary and acute care, wellness programs, pharmacy services, disease management, and health and fitness services. Overall, the company’s Smart Scores show a mixed outlook, with strengths in dividends and value, but potential weaknesses in growth and resilience.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma